Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -42.59%11.75M | -14.75%14.38M | 23.58%15.25M | 77.25%72.98M | 141.57%23.3M | 119.51%20.47M | 65.89%16.87M | 2.54%12.34M | -31.73%41.17M | -29.98%9.65M |
| Selling and administrative expenses | -19.87%2.25M | 122.72%5.53M | 36.58%2.93M | 12.24%11.47M | 45.18%4.03M | 20.88%2.81M | -0.12%2.48M | -18.47%2.15M | 15.90%10.22M | 7.67%2.78M |
| -Selling and marketing expense | -71.53%41K | -61.03%53K | -40.88%107K | 53.63%699K | 91.94%238K | 28.57%144K | 16.24%136K | 77.45%181K | -29.68%455K | 5.98%124K |
| -General and administrative expense | -17.08%2.21M | 133.38%5.48M | 43.72%2.82M | 10.31%10.77M | 42.99%3.8M | 20.49%2.66M | -0.93%2.35M | -22.33%1.97M | 19.51%9.76M | 7.75%2.65M |
| Other operating expenses | -46.20%9.5M | -38.47%8.85M | 20.84%12.32M | 98.71%61.51M | 180.55%19.27M | 152.24%17.66M | 87.24%14.38M | 8.42%10.19M | -39.89%30.95M | -38.65%6.87M |
| Operating profit | 42.59%-11.75M | 14.75%-14.38M | -23.58%-15.25M | -77.25%-72.98M | -141.57%-23.3M | -119.51%-20.47M | -65.89%-16.87M | -2.54%-12.34M | 31.73%-41.17M | 29.98%-9.65M |
| Net non-operating interest income (expenses) | 6.72%-541K | -43.59%-1.23M | -103.39%-840K | -1,024.55%-4.11M | -1,370.86%-2.22M | -319.70%-580K | -601.75%-858K | -358.13%-413K | 21.31%444K | -199.34%-151K |
| Non-operating interest income | -13.52%550K | -60.33%121K | 15.31%708K | 63.56%965K | -931.48%-557K | 126.33%636K | 60.53%305K | 254.91%614K | 61.20%590K | -135.53%-54K |
| Non-operating interest expense | -10.28%1.09M | 16.34%1.35M | 50.73%1.55M | 3,372.60%5.07M | 1,615.46%1.66M | 7,052.94%1.22M | 6,021.05%1.16M | 7,800.00%1.03M | --146K | --97K |
| Other net income (expenses) | -73.97%63K | 14,413.58%11.76M | 242K | 81K | -129.04%-356K | -2,688.89%-251K | ||||
| Gain on sale of security | ---- | 2,300.00%1.94M | ---- | ---- | ---- | ---- | --81K | ---- | -107.63%-105K | --0 |
| Special income (charges) | --0 | --9.81M | ---- | --0 | --0 | --0 | --0 | ---- | ---251K | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --251K | ---- |
| -Gain on sale of property,plant,equipment | --0 | --9.81M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non-operating income (expenses) | -73.97%63K | ---- | ---- | ---- | ---- | --242K | ---- | ---- | ---- | ---- |
| Income before tax | 41.22%-12.23M | 78.16%-3.85M | -26.16%-16.09M | -87.62%-77.08M | -157.55%-25.88M | -129.64%-20.81M | -76.50%-17.64M | -6.46%-12.75M | 30.03%-41.08M | 26.29%-10.05M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 41.22%-12.23M | 78.16%-3.85M | -26.16%-16.09M | -87.62%-77.08M | -157.55%-25.88M | -129.64%-20.81M | -76.50%-17.64M | -6.46%-12.75M | 30.03%-41.08M | 26.29%-10.05M |
| Net income continuous operations | 41.22%-12.23M | 78.16%-3.85M | -26.16%-16.09M | -87.62%-77.08M | -157.55%-25.88M | -129.64%-20.81M | -76.50%-17.64M | -6.46%-12.75M | 30.03%-41.08M | 26.29%-10.05M |
| Noncontrolling interests | 35.00%-13K | -60.00%-16K | 4.76%-20K | 14.67%-64K | -8.33%-13K | 4.76%-20K | 56.52%-10K | -10.53%-21K | -27.12%-75K | 0.00%-12K |
| Net income attributable to the company | 41.23%-12.22M | 78.23%-3.84M | -26.21%-16.07M | -87.81%-77.02M | -157.73%-25.87M | -129.95%-20.79M | -76.81%-17.63M | -6.46%-12.73M | 30.09%-41.01M | 26.32%-10.04M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 41.23%-12.22M | 78.23%-3.84M | -26.21%-16.07M | -87.81%-77.02M | -157.73%-25.87M | -129.95%-20.79M | -76.81%-17.63M | -6.46%-12.73M | 30.09%-41.01M | 26.32%-10.04M |
| Diluted earnings per share | 46.15%-0.07 | 83.33%-0.02 | -25.00%-0.1 | -68.97%-0.49 | -128.57%-0.16 | -116.67%-0.13 | -100.00%-0.12 | 20.00%-0.08 | 44.23%-0.29 | 41.67%-0.07 |
| Basic earnings per share | 46.15%-0.07 | 83.33%-0.02 | -25.00%-0.1 | -68.97%-0.49 | -128.57%-0.16 | -116.67%-0.13 | -100.00%-0.12 | 20.00%-0.08 | 44.23%-0.29 | 41.67%-0.07 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.